Japour Anthony J 4
4 · Cocrystal Pharma, Inc. · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Japour Anthony J
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-07-25+148,000→ 148,000 totalExercise: $0.42Exp: 2032-07-25→ Common Stock (148,000 underlying)
Footnotes (1)
- [F1]The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.